or Try an Advanced Search...

    Technical Analysis for CPRX - Catalyst Pharmaceutical Partners, Inc.

    Grade Last Price % Change Price Change
    B 23.06 3.92% 0.87
    CPRX closed up 3.92 percent on Wednesday, January 15, 2025, on 1.37 times normal volume.
    5 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical CPRX trend table...
    Date Alert Name Type % Chg
    Cup with Handle Other 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Gapped Up Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    MACD Bullish Centerline Cross Bullish 3.92%
    Cup with Handle Other 3.92%
    Calm After Storm Range Contraction 3.92%
    Upper Bollinger Band Touch Strength 3.92%
    20 DMA Support Bullish 3.83%
    50 DMA Support Bullish 3.83%
    Older End-of-Day Signals for CPRX ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Upper Bollinger Band about 6 hours ago
    Rose Above Previous Day's High about 7 hours ago
    Up 3% about 7 hours ago
    Upper Bollinger Band Resistance about 7 hours ago
    60 Minute Opening Range Breakout about 8 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    CPRX Chart by TradingView

    Profile

    Catalyst Pharmaceutical Partners, Inc. operates as development-stage specialty pharmaceutical company. It focuses on the development and commercialization of novel prescription drugs targeting rare (orphan) neuromuscular and neurological diseases and disorders. The company's principal product includes Firdapse that is in Phase III clinical trial for the treatment of Lambert-Eaton Myasthenic Syndrome. It also develops CPP-115, a GABA aminotransferase inhibitor for the treatment of epilepsy and other selected central nervous disease indications; and CPP-109 for the treatment of Tourette Syndrome. Catalyst Pharmaceutical Partners, Inc. has strategic collaboration agreement with BioMarin. The company was founded in 2002 and is based in Coral Gables, Florida.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Pharmaceutical Health Sciences Medication Virotherapy Disorders Epilepsy Prescription Drugs Pharmaceutical Sciences Myasthenia Stage Specialty Pharmaceutical Pharmaceutical Partners Treatment Of Epilepsy Lambert Eaton Myasthenic Lambert Eaton Myasthenic Syndrome Tourette Syndrome Treatment Of Tourette Syndrome Urological Diseases

    Is CPRX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jan 14 BridgeBio Pharma Stock Earns 87 RS Rating
    Jan 13 Catalyst Pharmaceuticals: The Stars Align For Flagship FIRDAPSE
    Jan 9 Catalyst (CPRX) Soars 16.7%: Is Further Upside Left in the Stock?
    Jan 8 IBD Tech Leader Catalyst Rockets After Striking A Key Deal With Teva
    Jan 8 Catalyst stock climbs 15% on Firdapse litigation settlement
    Jan 8 Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Teva Pharmaceuticals
    Jan 3 Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
    Dec 27 Arcellx Stock Earns 82 Relative Strength Rating
    Dec 24 Neurocrine Biosciences Stock Sees RS Rating Upgrade
    Dec 24 Why Catalyst Pharmaceutical (CPRX) is a Top Momentum Stock for the Long-Term
    See more CPRX news...

    Comments

    Indicators

    Indicator Value
    52 Week High 24.27
    52 Week Low 13.1161
    Average Volume 1,093,477
    200-Day Moving Average 18.69
    50-Day Moving Average 21.80
    20-Day Moving Average 21.55
    10-Day Moving Average 21.56
    Average True Range 1.03
    RSI (14) 59.02
    ADX 19.61
    +DI 33.03
    -DI 15.34
    Chandelier Exit (Long, 3 ATRs) 20.92
    Chandelier Exit (Short, 3 ATRs) 22.23
    Upper Bollinger Bands 23.11
    Lower Bollinger Band 20.00
    Percent B (%b) 0.99
    BandWidth 14.41
    MACD Line 0.15
    MACD Signal Line -0.04
    MACD Histogram 0.1887
    Fundamentals Value
    Market Cap 2.75 Billion
    Num Shares 119 Million
    EPS 0.55
    Price-to-Earnings (P/E) Ratio 41.93
    Price-to-Sales 4.66
    Price-to-Book 4.66
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 24.59
    Resistance 3 (R3) 24.44 23.79 24.34
    Resistance 2 (R2) 23.79 23.40 23.86 24.25
    Resistance 1 (R1) 23.42 23.16 23.61 23.57 24.16
    Pivot Point 22.77 22.77 22.86 22.84 22.77
    Support 1 (S1) 22.40 22.38 22.59 22.55 21.96
    Support 2 (S2) 21.75 22.14 21.82 21.87
    Support 3 (S3) 21.38 21.75 21.79
    Support 4 (S4) 21.53